Mutations in K-ras and p53 are among the most common genetic alterations in non-small cell lung cancer. To determine mechanisms of lung tumorigenesis, we obtained K-ras LA1 mice (developed in the laboratory of T. Jacks, MIT), which develop lung tumors with 100% frequency. To establish the molecular mechanisms of p53 function in the lung epithelium and its relation to neoplastic transformation, we disrupted wild-type p53 activities by transgenically expressing an oncogenic mutant form of human p53 (R175H mutation) specifically in the lung epithelium of mice using the human surfactant protein C (SPC) promoter, SPC-DNp53 mice. The SPC-DNp53 mice were interbred with the K-ras LA1 mice with the expectation of oncogenic cooperativity and lung tumorigenesis. Mice in the C57BL/6 inbred strain of the four possible genotypes (K-ras+/DNp53+, K-ras+, DNp53+, and wild-type) were monitored for the development of lung tumors. The K-ras+/DNp53+ mice displayed multifocal lung tumors with a median survival of 218 days. K-ras+ littermates developed large lung tumors at a lower multiplicity with a median survival of 388 days. DNp53+ and wild-type littermates had a median survival >500 days and did not develop lung tumors. Alveolar hyperplasias with distinct cytology were detected in the K-ras+/DNp53+ and K-ras+ mice by day 80. Recent studies have demonstrated that expression of mutant K-ras in lung epithelial cells elicits inflammation that promotes carcinogenesis in mice. Moreover, our previous results showed that SPC-DNp53 mice displayed exaggerated inflammation after lung injury. Whether or not inflammation is further enhanced during lung tumorigenesis induced by the combination of oncogenic K-ras and mutant p53 has not been determined. Inflammatory cytokine profiles were performed on whole lung extracts at early stages of tumor development (day 55-105) to correlate progression with altered inflammation in the lung. Relative to wild-type, overall inflammatory cytokine levels in lung extracts from mice at early times of tumor progression appeared similar in K-ras+, elevated in DNp53+, and reduced in K-ras+/DNp53+ mice. Assessment of individual cytokines in K-ras+/DNp53+ mice suggested selective reduction of cytokines correlating with a T helper-2 (T h 2) phenotype. Linear regression analyses of cytokine levels versus age (a surrogate for tumor progression) revealed that the levels of only 5 cytokines [IL-12(p40), IL-17, KC, G-CSF and CCL2/MCP-1] increased in K-ras+/DNp53+ mice. Expression of these cytokines corresponds to induction of a T h 17 response and macrophage activation during progression of K-ras+/DNp53+ lung tumors. Relative to their male counterparts, female K-ras+/DNp53+ mice displayed significantly higher levels of T h 1 cytokines. In human lung adenocarcinoma, elevated serum levels of interferon-γ, a marker for the T h 1 phenotype, correlates with a worse prognosis (Surgery 131(1 Suppl):S236-41, 2002). These observations suggest that oncogenic cooperation between K-ras and mutant p53 promotes lung tumorigenesis by mo...
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.
customersupport@researchsolutions.com
10624 S. Eastern Ave., Ste. A-614
Henderson, NV 89052, USA
Copyright © 2024 scite LLC. All rights reserved.
Made with 💙 for researchers
Part of the Research Solutions Family.